Experts have highlighted the need to improve data collection for metastatic breast cancer, end the stigma surrounding the disease, and improve patient outcomes via equitable access to care, individualized treatment, multidisciplinary management, and use of evidence-based guidelines. Many patients with metastatic breast cancer feel abandoned and do not receive appropriate care, according to a report published in The Lancet.
Cancer research is a crucial pillar for countries to deliver more affordable, higher
quality, and more equitable cancer care. Patients treated in research-active hospitals
have better outcomes than patients who are not treated in these settings. However,
cancer in Europe is at a crossroads. Cancer was already a leading cause of premature
death before the COVID-19 pandemic, and the disastrous effects of the pandemic on
early diagnosis and treatment will probably set back cancer outcomes in Europe by
almost a decade.
LONDON and PHOENIX, March 01, 2022 (GLOBE NEWSWIRE) AccuStem Sciences, Inc. (OTC PINK: ACMSY), a life sciences company dedicated to improving outcomes for patients with cancer, today announced publication